Racemic N-sulfonyloxaziridines as highly diastereoselective enolate hydroxylating agents: enantioselective synthesis of (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide
(2011) Tetrahedron — Vol. 67, n° 47, p. 9173-9178 (2011)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 510.92 KB
Details
- Authors
- Abstract
- A new, highly enantioselective synthesis of (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide, a synthetic fragment of the experimental hepatitis C drug Telaprevir, has been described. Conjugate addition of the enantiomerically pure Davies lithium amide followed by hydroxylation of the in situ generated b-amino enolate was employed for the formation of the required stereogenic centres. Importantly, very high diastereoselectivities can still be achieved in the key-step when the relatively expensive and enantiopure (camphorsulfonyl)oxaziridine hydroxylating agent is replaced by racemic trans-N-sulfonyloxaziridines. Among the tested N-sulfonyloxaziridines the iso-propyl substituted analogue proved to be the ideal choice from an economic viewpoint.
- Affiliations
Johnson & Johnson Pharmaceutical Research and Development Chemical Process Research
Citations
Kiss, E., Marko, I., & Guillaume, M. (2011). Racemic N-sulfonyloxaziridines as highly diastereoselective enolate hydroxylating agents: enantioselective synthesis of (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide. Tetrahedron, 67(47), 9173-9178. https://doi.org/10.1016/j.tet.2011.09.090 (Original work published 2011)